HOSMAT Hospital, the dedicated orthopaedic care provider has now installed the 3rd generation CUVIS robotic surgery unit, at its facility in Bengaluru. This is the 2nd medical centre in Karnataka to have this latest automated robotic system after...
Leading contract manufacturing drug firm Akums Drugs & Pharmaceuticals plans to expand its presence globally and enhance product range as it looks to more than double its turnover to Rs 10,000 crore by 2028, as per the company's Joint Managing...
Oxurion NV, a biopharmaceutical company, announced that it has prevailed in final proceedings before the European Patent Office in opposition to Dyax Corp.’s European patents 1 854 477 and 2 374 472. The European Board of Appeal announced its...
Oncologists at Apollo Cancer Centre, Bangalore have successfully performed endoscopic trans canal excision of facial nerve schwannoma on a 35-year-old patient who was suffering from right-sided facial weakness for the last two years....
Drug firm Eli Lilly and Company (India) said it has launched a product to treat early stage breast cancer after receiving approval from the Drug Controller General of India. The company has introduced Ramiven in strengths of 50 mg, 100 mg, 150 mg...
India’s pharma exports have increased 138 per cent in April-October 2022-23 compared to the same period of 2013-14 when the country became the pharmacy for the world...
Okyo Pharma Limited, an ophthalmology-focused bio-pharmaceutical company, announced that it filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for the development of OK-101 to treat dry eye disease...
Novel innovations are now actively hitting the market with an expectation to alter the course of drug manufacturing. In this article, we have listed the top trends in the RNA therapeutic industry:
Merck, known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (Imago) announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in...
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Procardia XL extended-release tablets, 30 mg, 60 mg and 90 mg, of Pfizer Inc...
, CDSCO.jpg)
